Skip Navigation

Skip Navigation

Issue No. 40  | October 02, 2009
View HTML version

AIDSinfo.nih.gov is pleased to provide you with a weekly update of highlights about what has happened in the world of HIV/AIDS treatment, prevention, and research. We hope you find this encapsulated view of HIV/AIDS news useful.

Globe of the earth

FDA Approves New Screening Test for Donor Blood Products and Organs

"The U. S. Food and Drug Administration today announced approval of the Abbott Prism HIV O Plus assay, as a screening tool designed to detect the presence of certain antibodies to HIV. The assay is one of five assays that run on the fully automated Abbott Prism System....

"The Abbott Prism HIV O Plus assay detects antibodies to HIV type 1, groups M and O, and HIV type 2. It is the second donor screening test licensed for the detection of antibodies to HIV type 1, group O.

"The Abbott Prism HIV O Plus assay is licensed to screen donated blood and blood specimens from other living donors for these specific types of HIV and subgroups of HIV type 1. The assay is also licensed to screen specimens from organ donors when specimens are obtained while the donor’s heart is still beating and from cadavers."

More information is available:


Fall 2009 Issue of Mental Health AIDS Released

Mental Health AIDS, a quarterly biopsychosocial research update on HIV and mental health, is sponsored by the Center for Mental Health Services (CMHS) of the Substance Abuse and Mental Health Services Administration (SAMHSA) and is disseminated free of charge through the SAMHSA Web site in both PDF and HTML formats.

The Fall 2009 issue features "Psychotherapy Select: The Science of Matching Clients to Treatment."

In this tool box, a new instrument for identifying individuals who are "ready" for therapy is introduced. The discussion then centers on research findings that can help to promote productive matches between clinicians and clients. These findings also can help clinicians to select the type of therapy that holds the greatest promise for a positive clinical outcome. The tool box concludes with a focus on the development of an HIV-related pain management intervention and client characteristics associated with beneficial results.
 

More information is available:


Twitter - Stay connected FaceBook - Stay connected
ClinicalTrials.gov Info

Subscribe Info

Contact AIDSinfo
Download Adobe Acrobat(R) Reader TM to view PDF files located on this site.
ISSN 1558-3228